Burning questions left unanswered about the latest Alzheimer’s therapy
Here are the burning questions left unanswered by the success of lecanemab, the latest Alzheimer’s treatment from Biogen and Eisai.
Here are the burning questions left unanswered by the success of lecanemab, the latest Alzheimer’s treatment from Biogen and Eisai.
/PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing novel treatments for severe neurodegenerative diseases,…
“Every 90 Minutes” has been a tagline that organizations have used for over a decade to describe how often someone dies from ALS in the…
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis
There is a lot that the Bears Hall of Famer can’t do anymore, but he can still connect with the people who have been important…
Gland Pharma Ltd. announced on Tuesday that the US health government has approved its generic Edaravone injection for the treatment of amyotrophic lateral sclerosis.
The All of Us Research Program’s database of more than 770,000 people is proving to be a treasure trove for health researchers, who are using…
View G. Richard “Rich” Dodge. Jr.’s obituary, contribute to their memorial, see their funeral service details, and more.
In this presentation from C-Path’s rare and orphan disease program, you will see…
Experts are hopeful that objective biomarker measures for amyotrophic lateral sclerosis, such as the ones being developed by EverythingALS, will lead to more targeted, effective…
I didn’t know what an ALS advocate did. I wanted to help people living with and or impacted by this 100% fatal disease. Diagnosed with…